(Q40785107)

23 September 2017

title

Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile (English)

1 reference

23 September 2017

A W Schmidt

1

1 reference

23 September 2017

L A Lebel

series ordinal

2

1 reference

23 September 2017

H R Howard

series ordinal

3

1 reference

23 September 2017

S H Zorn

series ordinal

4

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

European Journal of Pharmacology

23 September 2017

published in

1 reference

23 September 2017

volume

425

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

197-201

1 reference

Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901188-8

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901188-8

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901188-8

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901188-8

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901188-8

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901188-8

Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901188-8

Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901188-8

10.1016/S0014-2999(01)01188-8

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference